Determination of plasma concentrations of dapsone, monoacetyl dapsone and pyrimethamine in human subjects dosed with maloprim.
A high-performance liquid chromatographic method was developed to enable dapsone, monoacetyl dapsone and pyrimethamine to be measured simultaneously in plasma samples from volunteers in England and Malaysia who had been dosed with Maloprim. Mean half-lives of 25 and 80 h were calculated for dapsone and pyrimethamine, respectively, but there was wide individual variation. All subjects were found to be classifiable as "slow acetylators".
D000328:Adult; D002851:Chromatography, High Pressure Liquid / Q000379:methods*; D003622:Dapsone / Q000031:analogs & derivatives* / Q000097:blood* / Q000627:therapeutic use*; D004338:Drug Combinations / Q000627:therapeutic use; D006207:Half-Life; D006801:Humans; D008288:Malaria / Q000097:blood / Q000188:drug therapy / Q000517:prevention & control; D008297:Male; D011739:Pyrimethamine / Q000097:blood* / Q000627:therapeutic use*
D004338:Drug Combinations; C001678:Maloprim; D003622:Dapsone; C018965:monoacetyldapsone; D011739:Pyrimethamine